Search Results for “artificial intelligence” – Page 3 – media

FDA Clears First Autonomous AI Diagnostic System Rolled out by University of Iowa Healthcare

The U.S. Food and Drug Administration approved the first autonomous artificial intelligence diagnostic system, IDx-DR and the University of Iowa Healthcare has become the first healthcare organization to implement it.
- Source: HealthcareIT News
- 943
- July 15, 2018
AI digital health New Approvals
Indian Healthcare Startup SigTuple Raised $19 Million AI Based Products Development

India, Bengaluru based SigTuple, a startup focusing on Artificial Intelligence for Healthcare has raised $19 million in their series B funding. The investment was led by IDG Ventures, pi Ventures Partners along with Accel, Axilor Ventures, VH Capital, Endiya Partners and Flipkart’s executive chairman Binny Bansal. The startup has also bagged venture debt from Trifecta Capital in this round. In an earlier investment round, the company raised $6.5 million from various investors.
- Source: Analytics India
- 708
- June 26, 2018
AI Company Insight digital health start ups
FDA Approval for AI Enabled Diabetes Software

The Food and Drug Administration (FDA) has granted approval for a request made by DreaMed regarding their artificial intelligence-enabled diabetic software, which is exclusively meant for the providers, who are managing Type 1 diabetes patients.
- Source: MobiHealthNews
- 858
- June 20, 2018
AI digital health FDA New Approvals type 1 diabetes
HHS Selects 8 Accelerators for AI Innovation

The United States, Department of Human & Health Services has been aiming to enhance patient care and health security for a long period of time. Recently the HHS selected eight accelerators to steer artificial intelligence innovation. The chosen accelerators will develop AI devices to solve challenging problems in daily patient care and health security.
- Source: Health ITAnalytics
- 796
- June 11, 2018
digital health Market Views mHealth
AI to Replace Doctors and Nurses for Tasks

University College London Hospital (UCLH) and the Alan Turing Institute are working together on Artificial Intelligence to carry out works which are traditionally done by the doctors and nurses; from deciding which accidental and emergency patients to be consulted first to diagnosing cancer on CT scan.
- Source: Ddu
- 762
- May 23, 2018
AI digital health New Approvals
Theresa May Urges Medical Fraternity to Adopt AI For Acute Cancer Diagnosis

Positive news that holds hope for the medical fraternity and patients is the urging by UK Prime Minister, Theresa May, for the adoption of artificial intelligence by the NHS and technology companies to diagnose critical diseases such as cancer.
- Source: Ddu
- 723
- May 23, 2018
AI Market Views NHS
Qventus raised $30M investment from Bessemer Venture Partners

Mountain View, California startup - Qventus a healthcare management tech platform which uses artificial intelligence to improve hospital workflow, closed at $30 million in series B funding which will be used to expand its platform. The funding was led by Bessemer Venture Partners along with few other participants. Including this latest funding, Qventus bagged total $43 million.
- Source: Ddu
- 534
- May 15, 2018
AI Company Insights digital health
FDA approves first AI-powered device to detect diabetic retinopathy

The FDA today approved the first medical device to harness artificial intelligence for the detection of diabetic retinopathy in adults who have diabetes.
- Source: Drug Delivery Business News
- 674
- April 13, 2018
AI FDA New Approvals
Insilico Medicine to launch R&D center and announce new research results in Taiwan ROC

Tuesday, March 20th, 2018, Insilico Medicine, a Baltimore-based artificial intelligence company specializing in drug discovery, biomarker development and aging research announced the launch of Insilico Taiwan, a subsidiary focusing on the development and validation of generative adversarial networks(GANs) and reinforcement learning for medicinal chemistry applications.
- Source: EurekAlert
- 582
- March 21, 2018
AI biomarker Company Insight Researches
Researchers develop new technology platform for cancer immunotherapy

Johns Hopkins researchers have invented a new class of immunotherapeutic agents that are more effective at harnessing the power of the immune system to fight cancer. Their approach results in significant inhibition of tumor growth, even against cancers which do not respond to existing immunotherapies used in the clinic. In collaboration with Insilico Medicine, a Baltimore-based leader in artificial intelligence for drug discovery, the team reports their results this week in Nature Communications.
- Source: immunotherapies
- 519
- February 27, 2018
cancer immunotherapies Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.